PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen
Mingyu Liu(Sun Yat-sen University), Limin Zheng(Weifang University of Science and Technology), Lan Zhu(Sun Yat-sen University), Lu Wang(Sun Yat-sen University), Junyu Xu(Sun Yat-sen University), Yulan Weng(Biocon (Switzerland)), Qiaomin Hua(Biocon (Switzerland)), Huiling Lin(Sun Yat-sen University), Shufeng Luo(Central South University), Chong Wu(Sun Yat-sen University), Tiebang Kang(Sun Yat-sen University), Haitian Chen(Sun Yat-sen University), Zhenhong Guo(Second Military Medical University), Shi‐Mei Zhuang(Sun Yat-sen University), Jinheng Li(Sun Yat-sen University)
Cited by 37
Related Papers
RAB31 marks and controls an ESCRT-independent exosome pathway
|Cell Research|2020|472
A hMTR4‐PDIA3P1‐miR‐125/124‐TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance
|Hepatology|2019|192
Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis
|Journal of Clinical Investigation|2018|190
EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2019|183